CANCER BIOLOGY & THERAPY

期刊名
CANCER BIOLOGY & THERAPY

CANCER BIOL THER

ISSN / eISSN
1538-4047 / 1555-8576
目标和范围
Cancer, the second leading cause of death, is a heterogenous group of over 100 diseases. Cancer is characterized by disordered and deregulated cellular and stromal proliferation accompanied by reduced cell death with the ability to survive under stresses of nutrient and growth factor deprivation, hypoxia, and loss of cell-to-cell contacts. At the molecular level, cancer is a genetic disease that develops due to the accumulation of mutations over time in somatic cells. The phenotype includes genomic instability and chromosomal aneuploidy that allows for acceleration of genetic change. Malignant transformation and tumor progression of any cell requires immortalization, loss of checkpoint control, deregulation of growth, and survival. A tremendous amount has been learned about the numerous cellular and molecular genetic changes and the host-tumor interactions that accompany tumor development and progression. It is the goal of the field of Molecular Oncology to use this knowledge to understand cancer pathogenesis and drug action, as well as to develop more effective diagnostic and therapeutic strategies for cancer. This includes preventative strategies as well as approaches to treat metastases. With the availability of the human genome sequence and genomic and proteomic approaches, a wealth of tools and resources are generating even more information. The challenge will be to make biological sense out of the information, to develop appropriate models and hypotheses and to translate information for the clinicians and the benefit of their patients. Cancer Biology & Therapy aims to publish original research on the molecular basis of cancer, including articles with translational relevance to diagnosis or therapy. We will include timely reviews covering the broad scope of the journal. The journal will also publish op-ed pieces and meeting reports of interest. The goal is to foster communication and rapid exchange of information through timely publication of important results using traditional as well as electronic formats. The journal and the outstanding Editorial Board will strive to maintain the highest standards for excellence in all activities to generate a valuable resource.
研究方向

肿瘤学

CiteScore
7.00 查看趋势图
CiteScore 学科排名
类别 分区 排名
Medicine - Oncology Q1 #94/404
Medicine - Pharmacology Q2 #90/313
Medicine - Cancer Research Q2 #82/230
Medicine - Molecular Medicine Q2 #65/178
Web of Science 核心收藏夹
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
类别 (Journal Citation Reports 2024) 分区
ONCOLOGY Q2
H-index
101
出版国家或地区
UNITED STATES
出版商
Landes Bioscience
出版周期
Monthly
出版年份
2002
年文章数
81
Open Access
NO
通讯方式
LANDES BIOSCIENCE, 1002 WEST AVENUE, 2ND FLOOR, AUSTIN, USA, TX, 78701
认证评论
注: 认证评论选取于全球各个学术评论平台和社交媒体。
A very trashy magazine, took 6 months for the first review, and had to keep urging for minor revisions. After the revisions, there was no news for 14 months. They didn't reply to emails, so I withdrew the submission without waiting any longer. It was too much of a delay. I suggest that students should not submit to this magazine, it's a huge disappointment!!!
2021-04-30
May I ask if withdrawing a submission requires writing directly to the editor or withdrawing it through the system? Do I need to wait for a response from the editorial department before resubmitting?
2022-06-10

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now